Clinical Trials Directory

Trials / Completed

CompletedNCT01775579

Evaluating a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium

Randomized, Open Label, Multiple-Dose, 6-sequence, 3-period, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Metformin Hydrochloride and Rosuvastatin Calcium in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Hanmi Pharmaceutical Company Limited · Industry
Sex
Male
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

We investigate the potential pharmacokinetic drug-drug interaction between metformin extended release and rosuvastatin in healthy male volunteers who receive metformin extended release alone, rosuvastatin alone, and both together in a 3 period repeatedly.

Conditions

Interventions

TypeNameDescription
DRUGGlucophage SR tablet 750 mg, Crestor tablet 20 mg

Timeline

Start date
2013-01-01
Primary completion
2013-03-01
Completion
2013-06-01
First posted
2013-01-25
Last updated
2013-08-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01775579. Inclusion in this directory is not an endorsement.